At the 2015 annual meeting of the American Association of Neurological Surgeons, held in Washington, D.C., in May, Dr. Susan Pannullo was elected to a three-year term on the Board of Directors. Dr. Pannullo, who is Director of Neuro-oncology and Director of Neurosurgical Radiosurgery in the Department of Neurological Surgery will serve on the Strategic Planning Committee and the Education and Practice Management Committee.
“I am looking forward to serving organized neurosurgery in this leadership position,” says Dr. Pannullo, who is one of the few neurosurgeons in the world with a neurosurgical practice focused only on stereotactic radiosurgery, and one of the few neurosurgeons in the country with access to a CyberKnife, Gamma Knife, and Linear Accelerator (LINAC) to conduct stereotactic radiosurgery procedures.
Dr. Pannullo received her medical degree from Cornell University Medical College in 1987. Following a medicine internship at Harvard-Beth Israel Medical Center, she completed a neurology residency at New York Hospital-Cornell Medical Center in 1991. From 1991 to 1992, she was an American Cancer Society Fellow in Neuro-oncology at Memorial Sloan-Kettering Cancer Center. She then completed a second residency in neurological surgery at New York Hospital-Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in 1997, becoming the program’s first female graduate.
Dr. Pannullo’s research background includes clinical studies at Memorial Sloan-Kettering Cancer Center as well as laboratory research at the National Institutes of Health in Bethesda, Maryland. She currently oversees and directs the Department of Neurological Surgery’s numerous single-center and multi-center brain tumor clinical trials.
